Search

Your search keyword '"Zoia, Chiara Paola"' showing total 129 results

Search Constraints

Start Over You searched for: Author "Zoia, Chiara Paola" Remove constraint Author: "Zoia, Chiara Paola"
129 results on '"Zoia, Chiara Paola"'

Search Results

1. Harmonization of sensorimotor deficit assessment in a registered multicentre pre-clinical randomized controlled trial using two models of ischemic stroke

2. Glibenclamide-Loaded Engineered Nanovectors (GNVs) Modulate Autophagy and NLRP3-Inflammasome Activation

5. Author Correction: Common variants in Alzheimer’s disease and risk stratification by polygenic risk scores

6. sj-pdf-1-jcb-10.1177_0271678X231159958 - Supplemental material for Harmonization of sensorimotor deficit assessment in a registered multicentre pre-clinical randomized controlled trial using two models of ischemic stroke

7. Alzheimer's Disease Prevention through Natural Compounds: Cell- Free, In Vitro, and In Vivo Dissection of Hop (Humulus lupulus L.) Multitarget Activity

8. Alzheimer’s Disease Prevention through Natural Compounds: Cell-Free, In Vitro, and In Vivo Dissection of Hop (Humulus lupulus L.) Multitarget Activity

9. Modulation of MAPK- and PI3/AKT-Dependent Autophagy Signaling by Stavudine (D4T) in PBMC of Alzheimer’s Disease Patients

11. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

12. Multicentre translational Trial of Remote Ischaemic Conditioning in Acute Ischaemic Stroke (TRICS): protocol of multicentre, parallel group, randomised, preclinical trial in female and male rat and mouse from the Italian Stroke Organization (ISO) Basic Science network

13. Multicentre translational Trial of Remote Ischaemic Conditioning in Acute Ischaemic Stroke (TRICS): protocol of multicentre, parallel group, randomised, preclinical trial in female and male rat and mouse from the Italian Stroke Organization (ISO) Basic Science networkMulticentre translational Trial of Remote Ischaemic Conditioning in Acute Ischaemic Stroke (TRICS): protocol of multicentre, parallel group, randomised, preclinical trial in female and male rat and mouse from the Italian Stroke Organization (ISO) Basic Science network

14. Modulation of RAS and PI3-AKT pathway by Stavudine (d4T) in PBMC of Alzheimer’s Disease Patients

17. Oxidative stress and altered mitochondrial dynamics in neurodegenerative processes

19. THE TOXICITY OF AMYLOID-BETA OLIGOMERS AND TAU HYPERPHOSPHORYLATION ARE PREVENTED FROM LIPID-BASED NANOPARTICLES IN HUMAN PRIMARY FIBOBLASTS

21. Modulation of mapk phosphorylation in fibroblasts from alzheimer patients: erk involvment in glutamate transport and tau hyperphosporylation

22. Lipid-based nanoparticles counteract the oligomer abeta toxicity and tau phosphorylation in an ex-vivo biomolecular model of alzheimer disease

23. Behavioural Anomalies in Neurodegenerative Diseases: Role of the Immune Response

24. THE TOXICITY OF AMYLOID-BETA OLIGOMERS AND TAU HYPERPHOSPHORYLATION ARE PREVENTED FROM LIPID-BASED NANOPARTICLES IN HUMAN PRIMARY FIBOBLASTS

25. Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study

26. Donepezil modulates the endogenous immune response: implications for Alzheimer's disease

27. Lipid-based nanoparticles counteract the oligomer abeta toxicity and tau phosphorylation in an ex-vivo biomolecular model of alzheimer disease

28. Modulation of mapk phosphorylation in fibroblasts from alzheimer patients: erk involvment in glutamate transport and tau hyperphosporylation

29. Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study

30. Behavioural Anomalies in Neurodegenerative Diseases: Role of the Immune Response

31. MAPK phosphorylation in fibroblasts from Alzheimer's disease patients: ERK involvement in EAAT1 expression and modulation with disease severity

34. Longitudinal effects on plasma abeta levels of imatinib, a gamma-secretase activating protein inhibitor

35. Donepezil modulates the endogenous immune response in Alzheimer’s disease, an ex vivo and in vitro study

41. Glutamatergic Homeostasis Impairment in Multiple Sclerosis Patients

43. Oxidative stress and glutamate uptake impairment in Multiple Sclerosis: any possible relationship?

46. Novel therapeutic targets in neuropsychiatric disorders: the neuroepigenome

49. Imunohystochemical characterization of the distribution of glutamate receptors, 'high affinity' membrane bound glutamate transporters and of Glutamate Carboxipeptidase II (GCPII) in in vitro cultures of embryonic dorsal root ganglia

Catalog

Books, media, physical & digital resources